Healthcare Industry News: RaySearch Laboratories
News Release - March 19, 2014
RaySearch Secures Distribution of Raystation(R) in Australia and New ZealandSTOCKHOLM--(Healthcare Sales & Marketing Network)--RaySearch Laboratories AB (STO:RAYB) has entered into an exclusive distribution agreement with AlphaXRT (formerly CMS Alphatech) based in Sydney, Australia and Auckland, New Zealand. The agreement means that AlphaXRT will be fully responsible for marketing, sales and service of RaySearch’s proprietary treatment planning system RayStation® in Australia and New Zealand from April 1, 2014.
Australasia is a well-established, world renowned and growing radiation therapy market. AlphaXRT is a leading distributor of software and equipment used in the treatment of cancer and represents a wide range of respected international suppliers. The company was founded in 1990 and the dedicated sales and support team at AlphaXRT are highly experienced in the field of radiation therapy treatment planning systems and serve all radiation therapy centres in Australia and New Zealand.
“AlphaXRT is delighted to be representing RaySearch Laboratories in the treatment planning market in Australasia. RaySearch have a longstanding reputation in treatment planning solutions and RayStation® is the leading independent treatment planning system available. We look forward to working with RaySearch to promote RayStation® to our customers in the region”, says Richard Neale, Managing Director of AlphaXRT.
“AlphaXRT is a leading distributor of advanced radiation therapy equipment with a long track record, so we are of course delighted that they have elected to partner with RaySearch. We will now work closely together with AlphaXRT’s experienced experts to satisfy the needs of existing and future RayStation® customers and I am fully convinced that this collaboration will be highly fruitful for both companies”, says Johan Löf, CEO of RaySearch.
RayStation® integrates all RaySearch’s advanced treatment planning solutions into a flexible treatment planning system. It combines unique features such as multi-criteria optimization tools with full support for 4D adaptive radiation therapy. It also includes functionality such as RaySearch’s market-leading algorithms for IMRT and VMAT optimization and highly accurate dose engines for photon, electron and proton therapy. The system is built on the latest software architecture and has a graphical user interface offering state-of-the-art usability.
RaySearch Laboratories is a medical technology company that develops advanced software solutions for improved radiation therapy of cancer. RaySearch’s products are mainly sold through license agreements with leading partners such as Philips, Nucletron, IBA, Varian and Brainlab. To date, 15 products have been launched through partners and RaySearch’s software is used at over 2,300 clinics in more than 30 countries. In addition, RaySearch offers the proprietary treatment planning system RayStation® directly to clinics. RaySearch was founded in 2000 as a spin-off from Karolinska Institutet in Stockholm and the company is listed in the Small Cap segment on NASDAQ OMX Stockholm.
For more information about RaySearch, visit www.raysearchlabs.com
Source: RaySearch Laboratories
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.